Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00123
|
|||||
Drug Name |
Oxypurinol
|
|||||
Synonyms |
Oxypurinol (intravenous)
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Heart failure [ICD11: BD1Z] | Phase 2/3 | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C5H4N4O2
|
|||||
Canonical SMILES |
C1=NNC2=C1C(=O)NC(=O)N2
|
|||||
InChI |
InChI=1S/C5H4N4O2/c10-4-2-1-6-9-3(2)7-5(11)8-4/h1H,(H3,6,7,8,9,10,11)
|
|||||
InChIKey |
HXNFUBHNUDHIGC-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 2465-59-0
|
|||||
Pharmaceutical Properties | Molecular Weight | 152.11 | Topological Polar Surface Area | 86.9 | ||
Heavy Atom Count | 11 | Rotatable Bond Count | 0 | |||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 3 | |||
XLogP |
-0.9
|
|||||
PubChem CID | ||||||
ChEBI ID |
CHEBI:28315
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | URAT1 | Transporter Info | Urate anion exchanger 1 | Substrate | [2] | |
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | URAT1 | Transporter Info | Km = 794 microM | Oocytes-URAT1 | [2] | |
References | ||||||
1 | ClinicalTrials.gov (NCT00063687) Oxypurinol Compared With Placebo for Class III-IV NYHA Congestive Heart Failure | |||||
2 | Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone. Drug Metab Dispos. 2005 Dec;33(12):1791-5. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.